🔎 Trials Near Me

መነሻ › ክሮኒክ ማይሎይድ ሉኬሚያ › Texas › Houston

በHouston፣ TX ለክሮኒክ ማይሎይድ ሉኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች

ለክሮኒክ ማይሎይድ ሉኬሚያ የሚደረጉ 18 ጥናቶች በHouston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • UT MD Anderson Cancer Center, Houston
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Texas Children's Hospital, Houston
እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801

Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06817720

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The University of Texas M. D. Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07269470

Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06236724

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • M D Anderson Cancer Center, Houston
እድሜ 1 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT03630991

Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • M D Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT01746836

Study of Olverembatinib (HQP1351) in Patients With CML-CP

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Ascentage Investigative Site #1501, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06423911

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital - Baylor Medical Center, Houston
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT01351545

Asciminib Roll-over Study

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • Uni Of TX MD Anderson Cancer Cntr, Houston
እድሜ ከ7 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT04877522

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • M D Anderson Cancer Center, Houston
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ20 ሜይ 2026 · NCT02115295

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • University of Texas MD Anderson Cancer Center, Houston
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT00816114

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኤፕሪ 2026 · NCT05304377

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • MD Anderson, Houston
እድሜ ከ18 እስከ 66 · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06859424

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • MD Anderson Cancer Center, Houston
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ማርች 2026 · NCT06994676

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • The University of Texas M.D. Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጃንዩ 2026 · NCT06163430

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኖቬም 2025 · NCT04260022

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of Texas MD Anderson Cancer Center, Houston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ፌብሩ 2025 · NCT06088888

በሌሎች ከተሞች ለክሮኒክ ማይሎይድ ሉኬሚያ የሚደረጉ ጥናቶች

በHouston ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።